Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
05/2003
05/01/2003US20030082197 Administering complex of heat shock protein and antigen
05/01/2003US20030082195 Method of enhancing an immune response
05/01/2003US20030082190 Fusion molecules and treatment of IgE-mediated allergic diseases
05/01/2003US20030082184 Uses of mammalian cytokine; related reagents
05/01/2003US20030082181 Growth differentiation factor-8
05/01/2003US20030082176 Therapy for metabolism disorders
05/01/2003US20030082175 April receptor (BCMA) and uses thereof
05/01/2003US20030082174 Novel proteins and nucleic acids encoding same
05/01/2003US20030082173 Screening drugs that block lymphocytes; genetic engineered rodent
05/01/2003US20030082172 Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
05/01/2003US20030082166 Compounds and methods for modulating nonclassical cadherin-mediated functions
05/01/2003US20030082162 Therapy for genetic disorders in humans, animals; polypeptide coding antitrypsin
05/01/2003US20030082161 Efficient gene therapy; sustained release
05/01/2003US20030082159 Lentiviral vector-mediated gene transfer and uses thereof
05/01/2003US20030082158 Production of transduced hematopoietic progenitor cells
05/01/2003US20030082155 Antidiabetic agents; cell differentiation of stem cells
05/01/2003US20030082154 Fusogenic lipids and vesicles
05/01/2003US20030082153 Stem cells that transform to beating cardiomyocytes
05/01/2003US20030082152 Animal growth regulators; controlling cell differentiation; tissue engineering
05/01/2003US20030082150 Recombinant adenoviral vectors for human tumour gene therapy
05/01/2003US20030082149 Inhibition of a target messenger rna with a modified u1 small nuclear rna
05/01/2003US20030082148 Methods and device compositions for the recruitment of cells to blood contacting surfaces in vivo
05/01/2003US20030082146 Genetic enginnering; removal, replacement of vector
05/01/2003US20030082145 Adeno-associated virus materials and methods
05/01/2003US20030082144 A viral nucleic acid construct for the high level expression of a heterologous protein in an insect cell; using baculovirus expression vector system for exogenous proteins production
05/01/2003US20030082143 Filamentous phage particles having a ligand on surface for delivering a therapeutic gene to a cell; gene therapy
05/01/2003US20030082142 Replication incompetent herpes viruses for use in gene therapy
05/01/2003US20030082140 Increasing the amount of the cell differentiation associated protein, MDA-7 and decreasing RAS gene activity by administering a viral vector comprising an MDA-7 gene and an antisense ras oligonucleotide; treating pancreatic cancer
05/01/2003US20030082137 Interleukin-3 gene therapy for cancer
05/01/2003US20030080160 Liquid droplet ejecting method and a liquid droplet ejection apparatus
05/01/2003CA2842429A1 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
05/01/2003CA2793019A1 Humanized antibodies
05/01/2003CA2675409A1 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
05/01/2003CA2478681A1 Telomerase interference
05/01/2003CA2470197A1 Mycobacterial genes down-regulated during latency
05/01/2003CA2468125A1 Target specific screening and its use for identifying target binders
05/01/2003CA2466732A1 Telomerase interference
05/01/2003CA2465288A1 Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample
05/01/2003CA2465274A1 Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample
05/01/2003CA2465261A1 Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis
05/01/2003CA2465066A1 Process for producing beta 1,3-n-acetylglucosaminyl transferase and n-acetylglucosamine-containing complex carbohydrate
05/01/2003CA2464795A1 Thymosin augmentation of genetic immunization
05/01/2003CA2464700A1 Ibc-1 (invasive breast cancer-1), a putative oncogene amplified in breast cancer
05/01/2003CA2464695A1 Il-13 mutein proteins, antibodies, compositions, methods and uses
05/01/2003CA2464464A1 Transfection kinetics and structural promoters
05/01/2003CA2464462A1 Nucleic acid isolation method and apparatus for performing same
05/01/2003CA2464460A1 In vitro micro-organs, and uses related thereto
05/01/2003CA2464426A1 Synthetic herbicide resistance gene
05/01/2003CA2464417A1 Promoters to control cell differentiation
05/01/2003CA2464394A1 Methods and compositions for inducing tumor-specific cytotoxicity
05/01/2003CA2464372A1 Functional heavy chain antibodies, fragments thereof, library thereof and methods of production thereof
05/01/2003CA2464349A1 Mutant purine nucleoside phosphorylase proteins and cellular delivery thereof
05/01/2003CA2464344A1 Ee3-protein family and corresponding dna sequences
05/01/2003CA2464239A1 Psma antibodies and protein multimers
05/01/2003CA2464088A1 Stem cells that transform to beating cardiomyocytes
05/01/2003CA2463982A1 Method of determining a genetic structure of prokaryote
05/01/2003CA2463960A1 Transient immortalization
05/01/2003CA2463772A1 Thrombin-cleavable chimeric proteins
05/01/2003CA2463746A1 Methods and compositions to evaluate antibody treatment response
05/01/2003CA2463695A1 Manipulation of starch granule size and number
05/01/2003CA2463420A1 Methods for detecting genetic haplotypes by interaction with probes
05/01/2003CA2463398A1 Aromatic methyltransferases and uses thereof
05/01/2003CA2463326A1 Method of elevating photosynthesis speed of plant by improving pyruvate phosphate dikinase
05/01/2003CA2462712A1 Pig mast cell cultures and uses thereof
05/01/2003CA2461665A1 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
05/01/2003CA2461543A1 Sperm factor sequences
05/01/2003CA2460665A1 Peptides and proteins binding to glu-pro motifs, therapeutical compositions containing them and their applications
05/01/2003CA2454361A1 Humanized antibodies
04/2003
04/30/2003CN1415019A Method for making insulin precursors and insulin precursor analogus having improved fermentation yield in yeast
04/30/2003CN1415018A Microbiological method for producing aromatic aldehydes and/of carboxylic acids
04/30/2003CN1415017A UDP-glucose: aglycon-glacosyltransferase
04/30/2003CN1415016A Trichoderma reesei木聚糖酶 Trichoderma reesei xylanase
04/30/2003CN1415015A Process for biological preparation of L-pipecolic acid
04/30/2003CN1415014A Increased lysine production by gene amplification
04/30/2003CN1415013A BASB059 polypeptides from neisseria meningitidis
04/30/2003CN1415012A Human proteins binding to human tyrosine kinase HcK and genes encoding the same
04/30/2003CN1414976A Chimeric peptides used as immunogen and its antibody, and method for their use for immunization
04/30/2003CN1414975A Sex-chromosome-specific proteins, species specific and sperm specific protein and method for their identification and isolation
04/30/2003CN1414974A Method for making insulin precursors and insulin precursor analogs
04/30/2003CN1414973A Insecticidal proteins from bacillus thuringiensis
04/30/2003CN1414970A Transgenically produced fusion proteins
04/30/2003CN1414871A Placental human necerokinin B precursor
04/30/2003CN1414865A 癌症的治疗 Treatment of cancer
04/30/2003CN1414110A Using polymerase possessing 3 prime to 5 prime excision enzyme activity to proceed gene sequence analysis
04/30/2003CN1414107A Sequence resolving technology related to gene structure and function research
04/30/2003CN1414106A Method of clone gene and its application
04/30/2003CN1414105A Method of constructing genetic engineering organism based on in vivo isogenesis recombination
04/30/2003CN1414104A Construction method of conversion system of chlorella nitrate reductase gene defection type stable expression and its constructed conversion system
04/30/2003CN1414103A Human serine/threonine protein kitase, its coding sequence, preparation method and use
04/30/2003CN1414102A Binding region of erythrocyte binding protein of Plasmodium vivax and Plasmodium falciform
04/30/2003CN1414101A Desmocyte growth factor 11
04/30/2003CN1414100A Desmocyte growth factor 13
04/30/2003CN1414099A Linear expression carrier construction method need no clone
04/30/2003CN1414098A Linear expression carrier construction method need no clone
04/30/2003CN1414097A Breeding method of orchid
04/30/2003CN1414094A Using yeast secretion to express ruitipu enzyme
04/30/2003CN1414018A Binding region of erythrocyte binding protein of plasmodium vivax and plasmodium falciform
04/30/2003CN1414016A Leptospira adventitial protein, its code sequence and use
04/30/2003CN1414015A Leptospira adventitial protein, its code sequence and use
04/30/2003CN1414014A Leptospira adventitial protein its code sequence and use
1 ... 2532 2533 2534 2535 2536 2537 2538 2539 2540 2541 2542 2543 2544 2545 2546 2547 2548 2549 2550 2551 2552 ... 4023